Lindis Blood Care Announces Publication of Clinical Pilot Study Results Successfully Highlighting the Potential of CATUVAB(R) in the Removal of Tumor Cells from Surgical Blood in Peer-Reviewed Journal
MarketScreener,
DGAP-News: Lindis Blood Care GmbH / Key word(s): Study results 10.11.2021 / 10:00 The issuer is solely responsible for the…